Tenaya Therapeutics
Tenaya Therapeutics

Financials • Tenaya Therapeutics

TNYA

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2019
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2020
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2021
0
-70
-12
0%
L
279
L
-251
-
-64
-25
209
-89
-0
0
-
-
12/2022
0
-119
-123
0%
L
243
L
-187
-
-116
-21
78
-137
0
0
-
-
12/2023
0
-123
-123
0%
L
139
L
-105
-
-117
-1
4
-119
0
0
-
-
12/2024
0
-107
-123
0%
L
93
L
-61
-
-107
-1
48
-108
0
0
-
-
12/2025
0
-85
-12
0%
L
123
L
-101
-
-81
-1
108
-82
0
0
-
-

To see all financials—including updated, you must be Premium.